NCT05824286

HbA1c Prediction Model in Patients With Type 2 Diabetes

Efficacy and Safety of HbA1c Prediction Model Based on Self-monitoring Blood Glucose in Patients With Type 2 Diabetes

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 150 (estimated)
• Sponsor: Peking University People's Hospital · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

Patients with type 2 diabetes who have poor blood glucose control are enrolled to evaluate the efficacy and safety of the HbA1c prediction model for adjust the hypoglycemic treatment regimen, compared with the conventional treatment using self-monitoring blood glucose or glycated albumin.

Conditions

• Diabetes Mellitus, Type 2

Interventions

Type	Name	Description
OTHER	HbA1c prediction	HbA1c prediction model was developed based on fasting capillary blood glucose and postprandial capillary blood glucose from self-monitoring blood glucose. Since HbA1c was measured once every 3 month, self-monitoring blood glucose records were transferred to predicted HbA1c by prediction model every month.

Timeline

• Start date: 2023-01-04
• Primary completion: 2024-12-30
• Completion: 2024-12-30
• First posted: 2023-04-21
• Last updated: 2023-04-21

Locations

1 site across 1 country: China